Carbon dots as inhibitors of virus by activation of type I interferon response

被引：113
|
作者：
Du, Ting [1 ]
Liang, Jiangong [1 ]
Dong, Nan [2 ]
Liu, Lin [1 ]
Fang, Liurong [2 ]
Xiao, Shaobo [2 ]
Han, Heyou [1 ]
机构：
[1] Huazhong Agr Univ, Coll Sci, Coll Food Sci & Technol, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China
[2] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China
来源：
CARBON | 2016年 / 110卷
基金：
中国国家自然科学基金;
关键词：
QUANTUM DOTS; PSEUDORABIES-VIRUS; ANTIVIRAL ACTIVITY; SILVER NANOPARTICLES; NANODOTS; INFECTION; PROTEIN; SURFACE; CHARGE; ENTRY;
D O I：
10.1016/j.carbon.2016.09.032
中图分类号：
O64 [物理化学（理论化学）、化学物理学];
学科分类号：
070304 ; 081704 ;
摘要：
Carbon dots (CDs) has shown exciting potential in the field of bioscience and biotechnology due to their low toxicity, biological and ecological friendliness and desirable performance characteristics of quantum dots (QDs). However, the effects of CDs on viruses are still largely unknown. In this study, we investigate the effect of CDs on the replication of virus by using pseudorabies virus (PRV) and porcine reproductive and respiratory syndrome virus (PRRSV) as the models of DNA virus and RNA virus, respectively. Analyses of virus titers and the expression of viral proteins demonstrate that cells treated with CDs can significantly inhibit the multiplication of PRV and PRRSV. In mechanism, CDs treatment dramatically induces interferon-alpha (IFN-alpha) production and the expression of IFN-stimulating genes (ISGs) which in turn inhibits virus replication. Taken together, these results reveal a previously undefined role of CDs and provide a new strategy to develop antiviral agents. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：278 / 285
页数：8
相关论文
共 50 条
  • [21] Host Derivation of Sindbis Virus Influences Mammalian Type I Interferon Response to Infection
    Crawford, John M.
    Buechlein, Aaron M.
    Moline, Davis A.
    Rusch, Douglas B.
    Hardy, Richard W.
    VIRUSES-BASEL, 2023, 15 (08):
  • [22] Interplay between Zika virus and host type I interferon mediated immune response
    Ji X.
    Zhao H.
    Huang X.
    Li X.
    Qin C.
    Qin, Chengfeng (qincf@bmi.ac.cn), 2018, Chinese Academy of Sciences (63): : 495 - 501
  • [23] The immune response of ruminant livestock to bluetongue virus: From type I interferon to antibody
    Maclachlan, N. James
    Henderson, Christine
    Schwartz-Cornil, Isabelle
    Zientara, Stephan
    VIRUS RESEARCH, 2014, 182 : 71 - 77
  • [24] The brain parenchyma has a type I interferon response that can limit virus spread
    Drokhlyansky, Eugene
    Ayturka, Didem Goz
    Soh, Timothy K.
    Chrenek, Ryan
    O'Loughlin, Elaine
    Madore, Charlotte
    Butovsky, Oleg
    Cepko, Constance L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (01) : E95 - E104
  • [25] Epidermal growth factor receptor inhibitors trigger a type I interferon response in human skin
    Lulli, Daniela
    Carbone, Maria Luigia
    Pastore, Saveria
    ONCOTARGET, 2016, 7 (30) : 47777 - 47793
  • [26] LncRNAs in the Type I Interferon Antiviral Response
    Suarez, Beatriz
    Prats-Mari, Laura
    Unfried, Juan P.
    Fortes, Puri
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 34
  • [27] Type I interferon pathway activation in COPA syndrome
    Volpi, Stefano
    Tsui, Jessica
    Mariani, Marcello
    Pastorino, Claudia
    Caorsi, Roberta
    Sacco, Oliviero
    Ravelli, Angelo
    Shum, Anthony K.
    Gattorno, Marco
    Picco, Paolo
    CLINICAL IMMUNOLOGY, 2018, 187 : 33 - 36
  • [28] Inhibitors of human immunodeficiency virus type I
    Hazuda, Daria J.
    RETROVIROLOGY, 2006, 3
  • [29] Inhibitors of human immunodeficiency virus type I
    Daria J Hazuda
    Retrovirology, 3 (Suppl 1)
  • [30] A Type I interferon response is associated with increased mTOR activation in idiopathic multicentric Castleman disease
    Pai, Ruth-Anne Langan
    Japp, Alberto Sada
    Gonzalez, Michael
    Rasheed, Rozena F.
    Okumura, Mariko
    Arenas, Daniel
    Pierson, Sheila K.
    Layman, Awo Akosua Kesewa
    Kao, Charlly
    Hakonarson, Hakon
    van Rhee, Frits
    Betts, Michael R.
    Kambayashi, Taku
    Fajgenbaum, David C.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
12345